Literature DB >> 1816486

Virulence properties of Actinobacillus pleuropneumoniae.

T J Inzana1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1816486     DOI： 10.1016/0882-4010(91)90016-4

Source DB:  PubMed          Journal:  Microb Pathog        ISSN： 0882-4010            Impact factor:   3.738


× No keyword cloud information.
  19 in total

1.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

2.  Secreted proteases from Actinobacillus pleuropneumoniae serotype 1 degrade porcine gelatin, hemoglobin and immunoglobulin A.

Authors:  E Negrete-Abascal; V R Tenorio; J J Serrano; C Garcia; M de la Garza
Journal:  Can J Vet Res       Date:  1994-04       Impact factor: 1.310

3.  Binding of Actinobacillus pleuropneumoniae lipopolysaccharides to glycosphingolipids evaluated by thin-layer chromatography.

Authors:  M Abul-Milh; S E Paradis; J D Dubreuil; M Jacques
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils.

Authors:  R Jansen; J Briaire; H E Smith; P Dom; F Haesebrouck; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Transposon mutagenesis in Actinobacillus pleuropneumoniae with a Tn10 derivative.

Authors:  R I Tascon; E F Rodriguez-Ferri; C B Gutierrez-Martin; I Rodriguez-Barbosa; P Berche; J A Vazquez-Boland
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

6.  Structural analysis of the Actinobacillus pleuropneumoniae-RTX-toxin I (ApxI) operon.

Authors:  R Jansen; J Briaire; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.

Authors:  T J Inzana; J Todd; H P Veit
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin (Apx) operons: characterization of the ApxIII operons.

Authors:  R Jansen; J Briaire; A B van Geel; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.

Authors:  Abdul G Lone; Vincent Deslandes; John H E Nash; Mario Jacques; Janet I Macinnes
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

10.  malT knockout mutation invokes a stringent type gene-expression profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid.

Authors:  Abdul G Lone; Vincent Deslandes; John H E Nash; Mario Jacques; Janet I MacInnes
Journal:  BMC Microbiol       Date:  2009-09-14       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.